Medigus Ltd (Israel) Probability of Target Price Finishing Over Current Price

    MDGS -- Israel Stock  

    ILS 55.90  6.20  9.98%

    Medigus Ltd probability of target price tool provides mechanism to make assumptions about upside and downside potential of Medigus Ltd performance during a given time horizon utilizing its historical volatility. Please specify Medigus Ltd time horizon, a valid symbol (red box) and a target price (blue box) you would like Medigus Ltd odds to be computed. Please see also Stocks Correlation.
    Horizon     30 Days    Login   to change
    Symbol:
    Refresh Odds

    Medigus Ltd Target Price Odds to finish over

    Current PriceHorizonTarget PriceOdds to move above current price in 30 days
     55.90 30 days 55.90  ABOUT 72.78%
    Based on normal probability distribution, the odds of Medigus Ltd to move above current price in 30 days from now is about 72.78% (This Medigus Ltd probability density function shows the probability of Medigus Ltd Stock to fall within a particular range of prices over 30 days) .
    Assuming 30 trading days horizon, Medigus Ltd has beta of 0.7455 indicating as returns on market go up, Medigus Ltd average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Medigus Ltd will be expected to be much smaller as well. Additionally Medigus Ltd has an alpha of 0.3808 implying that it can potentially generate 0.3808% excess return over DOW after adjusting for the inherited market risk (beta).
     Medigus Ltd Price Density 
     
          
    Current Price   Target Price   
    α
    Alpha over DOW
    =0.38
    β
    Beta against DOW=0.75
    σ
    Overall volatility
    =3.98
    Ir
    Information ratio =0.09

    Medigus Ltd Alerts

    Medigus Ltd Alerts and Suggestions

    Medigus Ltd is not yet fully synchronised with the market data
    Medigus Ltd has very high historical volatility over the last 30 days
    Medigus Ltd has high likelihood to experience some financial distress in the next 2 years
    The company reported revenue of 420 K. Net Loss for the year was (1.61 M) with loss before overhead, payroll, taxes, and interest of (49 K).
    MEDIGUS has accumulated about 5.02 M in cash with (4.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
    Please see also Stocks Correlation. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
    Search macroaxis.com